KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Common Equity (2016 - 2025)

Elevance Health (ELV) has disclosed Common Equity for 17 consecutive years, with $44.1 billion as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity changed 0.46% to $44.1 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $44.1 billion, a 0.46% change, with the full-year FY2024 number at $41.3 billion, up 4.85% from a year prior.
  • Common Equity was $44.1 billion for Q3 2025 at Elevance Health, up from $43.9 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $44.1 billion in Q3 2025 to a low of $33.9 billion in Q1 2021.
  • A 5-year average of $38.8 billion and a median of $38.3 billion in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: rose 13.86% in 2024, then increased 0.46% in 2025.
  • Elevance Health's Common Equity stood at $36.1 billion in 2021, then rose by 0.53% to $36.3 billion in 2022, then grew by 8.46% to $39.4 billion in 2023, then increased by 4.85% to $41.3 billion in 2024, then increased by 6.7% to $44.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Common Equity are $44.1 billion (Q3 2025), $43.9 billion (Q2 2025), and $42.6 billion (Q1 2025).